首页> 外文期刊>Clinical nephrology >Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure.
【24h】

Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure.

机译:在慢性肾功能衰竭中降低血压可降低左心室质量指数。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: We have reported previously in a study of 85 non-diabetic patients with chronic renal failure (CRF) that 24-h ambulatory blood pressure (ABP) recording and echocardiography are required for accurate diagnosis of inadequate blood pressure (BP) control and early left ventricular hypertrophy (LVH). In this study we found that the only independent determinants of left ventricular (LV) mass were hypertension, male sex, body mass index (BMI) and anemia. Little is known about the progression of LVH in patients as they progress from moderate to end-stage renal failure. PATIENTS AND METHODS: We undertook a follow-up observational study in a cohort of 65 (26 male, 12 black Afro-Caribbean and 7 Asian) of those patients originally investigated. Patients who had reached end-stage renal failure (ESRF) were not studied. RESULTS: A statistically significant correlation was found between change in left ventricular mass index (LVMI) and change in mean ABP parameters (r = 0.27 (p<0.03) for 24-h systolic, r = 0.21 (p<0.05) for 24-h diastolic, r = 0.29 (p<0.02) for mean arterial pressure (MAP), r = 0.24 (p<0.05) for daytime systolic, r = 0.30 (p<0.02) for nocturnal systolic and r = 0.26 (p<0.05) for nocturnal diastolic BP). Hemoglobin concentration and BMI changed little between the two studies and no other statistically significant correlations were found in respect of any other parameters studied, which has allowed us to isolate the effect of one determinant - adequacy of BP control-upon LVH. CONCLUSION: In patients with moderate chronic renal impairment, reduction in BP is associated with reduction of LVMI over time. Among the antihypertensive agents ACE inhibitors appeared to have the greatest ability to reduce LV mass in the subjects with LVH at baseline. Larger interventional studies are needed to determine whether ACE inhibitors are superior to other anti-hypertensive agents in LVH regression in chronic renal failure patients.
机译:目的:我们先前在一项对85位患有慢性肾功能衰竭(CRF)的非糖尿病患者的研究中报告,需要24小时动态血压(ABP)记录和超声心动图检查才能准确诊断血压(BP)控制不足和早期左心室肥大(LVH)。在这项研究中,我们发现左心室(LV)肿块的唯一独立决定因素是高血压,男性,体重指数(BMI)和贫血。从中度肾衰竭到终末期肾功能衰竭的患者对LVH进展的了解甚少。患者和方法:我们对最初调查的65位患者(26位男性,12位黑人非洲加勒比海地区和7位亚洲患者)进行了一项随访观察研究。尚未达到终末期肾衰竭(ESRF)的患者。结果:发现左心室质量指数(LVMI)变化与平均ABP参数变化之间存在统计学意义的相关性(24小时收缩压r = 0.27(p <0.03),24小时收缩压r = 0.21(p <0.05))。 h舒张压,平均动脉压(MAP)r = 0.29(p <0.02),白天收缩压r = 0.24(p <0.05),夜间收缩压r = 0.30(p <0.02)和r = 0.26(p <0.05) ),用于夜间舒张压BP)。两项研究之间的血红蛋白浓度和BMI变化不大,并且在其他任何研究参数上均未发现其他统计学上显着的相关性,这使我们能够分离出一个决定因素-血压控制对LVH是否足够的影响。结论:在中度慢性肾功能不全患者中,随着时间的推移,血压降低与LVMI降低有关。在降压药中,ACEI抑制剂似乎具有在基线时患有LVH的受试者中降低LV质量的最大能力。需要更大的干预研究来确定在慢性肾衰竭患者的LVH回归中ACE抑制剂是否优于其他抗高血压药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号